Jove
Visualize
Contact Us

Related Experiment Videos

Vaccine development for HIV infection.

D Bolognesi1

  • 1Department of Surgery, Duke University Medical Center, Durham, NC 27710.

Journal of the American Academy of Dermatology
|June 1, 1990
PubMed
Summary

The human immunodeficiency virus (HIV) immune response involves antibodies and cells that fight infection. This response may be key to preventing new HIV infections, crucial for vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investment of palliative medicine in bridging the gap with academia: a call to action.

European journal of cancer (Oxford, England : 1990)·2011
Same author

How to identify and calculate glenoid bone deficit.

La Chirurgia degli organi di movimento·2006
Same author

A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.

AIDS research and human retroviruses·2000
Same author

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Nature medicine·1998
Same author

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Proceedings of the National Academy of Sciences of the United States of America·1992
Same author

HIV-1 neutralizing antibody and approaches to the envelope diversity problem.

Advances in experimental medicine and biology·1991
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • The immune response to human immunodeficiency virus (HIV) comprises humoral and cellular components.
  • These components demonstrate in vitro capabilities to inhibit viral infection and syncytium formation.
  • They also exhibit the capacity to lyse HIV-infected cells.

Purpose of the Study:

  • To investigate the role of the antiviral immune response in host defense against HIV.
  • To determine if the natural immune response can act as a barrier to de novo HIV infection.
  • To inform the development of effective HIV vaccine strategies.

Main Methods:

  • In vitro testing of immune response components (humoral and cellular).
  • Assays to measure inhibition of virus infection and syncytium formation.
  • Analysis of cell-mediated cytotoxicity against virus-infected cells.

Main Results:

  • The study highlights the dual action of humoral and cellular immunity against HIV in vitro.
  • Evidence suggests the immune response contributes to the prolonged asymptomatic phase in HIV patients.
  • The potential of this response as a barrier to initial HIV infection is indicated.

Conclusions:

  • The natural immune response to HIV is a critical factor in disease progression.
  • Understanding this response is essential for designing vaccines that elicit protective immunity.
  • Further research is needed to confirm its efficacy in preventing de novo HIV infection.

Related Experiment Videos